Cardiac Equipment Technologies Market By End Users (Hospitals, Home/ Ambulatory), By Products Type (Ecg, Defibrillators) , Industry Size, Growth, Share And Forecast To 2022
Key Findings
The global cardiac equipment technologies market is expected to grow at the CAGR of 5.9 % during 2016-2022 and is expected to reach $71000 million till 2022. Cardiac devices are the devices which are being used by hospitals, other cardiac centers when a patient is suffering from cardiac arrest. Defibrillators, pacemaker, ECG machines are some of the examples of cardiac devices.
There are many factors that pushes the cardiac devices such as advanced infrastructure with infused new professional skills in emerging markets, rising prevalence of cardiac diseases is the major reason. Technological advancement in cardiac devices also grows the global market. The introduction of remote monitoring and mobile telemetry in the cardiac field has led to an enhancement in revenues for alternate treatments, the ambulatory services segment and emergency medical services. Technological advancements such as the introduction of Pacemakers, subcutaneous implantable cardio verter -defibrillators, home-automated external defibrillators , magnetic resonance imaging (MRI), are boosting the growth of the defibrillator and implantable cardiac device markets.
The cardiac devices are technologically advanced devices that requires skilled professionals to operate. This increases the overall cost of cardiac devices services. High costs disables the reach of devices to every cardiac arrest patients. This acts as a restraint in the growth of global cardiac equipment’s technologies market.
Market Segment Insight
The global cardiac equipment technologies market is majorly segmented into end users, product type and regional outlook. The end users market is divided into hospitals, home/ ambulatory and others. Hospitals are the major users of cardiac equipment’s. Reason being patients largely prefer hospitals for the treatment of their cardiac problems. In products type market is divided into ECG this is subdivided into resting ECG, Stress ECG, Holter ECG and ECG by lead type. ECG by lead type is again subdivided into single lead, 3-6 lead and 12 lead. Defibrillators product type segment is divided into Implantable cardio verter defibrillators, external defibrillators, pacemakers and cardiac resynchronization therapy devices. ECG devices are majorly used while patient is suffering from cardiac arrest. Defibrillators are also growing popular amongst hospitals and ambulances due to its mobility. In regional outlook market, is divided into North America, Europe, Asia pacific and Rest of the World. North America dominates the global cardiac equipment technologies market. There are different market shares of cardiac devices regionally, the North America is the major player in this market. In North America U.S is the major country. Asia pacific is the fastest growing market due to increase in population. In Asia pacific, India, China and South Korea is the major country. Rest of the world is showing low market growth. Brazil is the major country in this region. The major reason for low growth of rest of the world region is low technological advancement, low disposal income as the cost of cardiac devices is very high. Europe is being a growing reason as government policies towards medical devices in this country is quite favorable. Growth in emerging countries is also at peak in this global market
Regional Insight
Globally the global cardiac equipment technologies market is divided into North America, Europe, Asia Pacific and Rest of the World. North America dominates the Global Cardiac Equipment Technologies Markets. North America shares around 47.21% market share. The reason for dominance of North America region is rising prevalence of cardiac arrests, increasing healthcare expenditure, technological development in medical devices field. United States and Canada are the major countries in North American region. Asia pacific is the fastest growing market in global cardiac equipment technologies market. China, India and South Korea are the major countries in this region. The major reason being is rising geriatric population, increasing awareness regarding cardiovascular diseases and so on. European region is also showing growth in global cardiac equipment technologies market having around 22.7% of market shares, the reason being technological advancement in medical field, favorable government policies related to cardiac devices. Rest of the world is showing low market growth. Brazil is the major country in this region. The major reason for low growth of rest of the world region is low technological advancement, low disposal income as the cost of cardiac devices is large.
Competitive Insights
Some of the keymarket players are Asahi Kasie Corp., Cook medical Inc., Contec medical systems Co. Ltd., Coherex medical Inc., Cardiac Science Corp., Boston scientific Corp., Biotronik SE & Co. KG, Lifewatch Services Inc., IVY Biomedical systems Inc., Heartware Inc., Heartsine technologies Inc., Edan instruments Inc., EBR systems Inc., etc. Acquisitions, new product development, collaborations, joint ventures, mergers and expansions are the key strategies adopted by the market players to sustain in the market
CHAP 1. METHODOLOGY & SCOPE 13
1.1. RESEARCH METHODOLOGY 13
1.2. RESEARCH SCOPE & ASSUMPTIONS 13
1.3. LIST OF DATA SOURCES 13
CHAP 2. EXECUTIVE SUMMARY 14
2.1. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET SUMMARY & KEY BUYING CRITERIA 14
2.2. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET OUTLOOK 14
2.3. MARKET SEGMENTATION ANALYSIS 14
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 14
2.5. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET VALUE CHAIN ANALYSIS 14
2.6. VENDOR LANDSCAPE 14
CHAP 3. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET 15
3.1. MARKET DRIVER ANALYSIS 15
3.1.1. RISING PREVALENCE OF CARDIOVASCULAR DISEASES 15
3.1.2. TECHNOLOGICAL ADVANCEMENT IN MEDICAL DEVICES FIELD 15
3.2. MARKET RESTRAINT ANALYSIS 15
3.2.1. HIGH COST OF CARDIAC EQUIPMENTS 15
3.2.2. TECHNOLOGICAL ADVANCEMENT CANNIBALIZES THE OLD TECHNOLOGY 15
3.3. KEY OPPORTUNITIES 15
3.3.1. LOW PENETRATION IN EMERGING ECONOMY 15
3.3.2. LOW HEALTH LITERACY 15
3.4. CHALLENGES 15
3.4.1. LACK OF SKILLED CARDIAC SPECIALISTS 15
3.4.2. COST RELATED ISSUES 15
CHAP 4. INDUSTRY ANALYSIS 16
4.1. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET– PORTER’S FIVE FORCE MODEL 16
4.2. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET– PESTEL ANALYSIS 16
4.3. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET– GAP ANALYSIS 16
CHAP 5. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY END USERS 2012-2022 ($ MILLION) 17
5.1. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY HOSPITALS 2012-2022 ($ MILLION) 17
5.2. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY HOME/ AMBULATORY 2012-2022 ($ MILLION) 17
5.3. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY OTHERS 2012-2022 ($ MILLION) 17
CHAP 6. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY PRODUCTS TYPE 2012-2022 ($ MILLION) 18
6.1. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY ECG 2012-2022 ($ MILLION) 18
6.2. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY DEFIBRILLATORS 2012-2022 ($ MILLION) 18
CHAP 7. GLOBAL ABLATION TECHNOLOGIES MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 19
7.1. GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY REGION 2012-2022 ($ MILLION) 19
7.2. NORTH AMERICA 19
7.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 19
7.2.3.1. U.S. 19
7.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.2.3.2. CANADA 19
7.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.2.3.3. MEXICO 19
7.2.3.3.1. MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.2.3.3.2. MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.3. EUROPE 20
7.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 20
7.3.3.1. GERMANY 20
7.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.3.3.2. UK 20
7.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.3.3.3. FRANCE 20
7.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.3.3.4. SPAIN 20
7.3.3.4.1. SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.3.3.4.2. SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.3.3.5. REST OF EUROPE 20
7.3.3.5.1. REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022($MILLION) 21
7.3.3.5.2. REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 21
7.4. ASIA PACIFIC 21
7.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLCATION 2012-2022 ($ MILLION) 21
7.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 21
7.4.3.1. CHINA 21
7.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.4.3.2. INDIA 21
7.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.4.3.3. JAPAN 21
7.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 21
7.4.3.4. SOUTH KOREA 21
7.4.3.4.1. SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.4.3.4.2. SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 21
7.4.3.5. REST OF APAC 22
7.4.3.5.1. REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.4.3.5.2. REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
7.5. REST OF THE WORLD 22
7.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
7.5.3. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 22
7.5.3.1. LATIN AMERICA 22
7.5.3.1.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.5.3.1.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
7.5.3.2. MIDDLE EAST AND AFRICA 22
7.5.3.2.1. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.5.3.2.2. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
CHAP 8. COMPETITIVE LANDSCAPE 23
8.1. ASAHI KASEI CORP. 24
8.1.2. SCOT ANALYSIS 24
8.1.3. PRODUCT BENCHMARKING 24
8.1.4. STRATEGIC INITIATIVES 24
8.2. BIOTRONIK SE & CO. KG 24
8.2.2. SCOT ANALYSIS 24
8.2.3. PRODUCT BENCHMARKING 24
8.2.4. STRATEGIC INITIATIVES 24
8.3. BOSTON SCIENTIFIC CORP. 24
8.3.2. SCOT ANALYSIS 24
8.3.3. PRODUCT BENCHMARKING 24
8.3.4. STRATEGIC INITIATIVES 24
8.4. CARDIAC SCIENCE CORP. 24
8.4.2. PRODUCT BENCHMARKING 24
8.4.3. STRATEGIC INITIATIVES 24
8.5. CARDICA INC. 24
8.5.2. SCOT ANALYSIS 24
8.5.3. PRODUCT BENCHMARKING 24
8.5.4. STRATEGIC INITIATIVES 24
8.6. CAREWELL HEALTHCARE 24
8.6.2. SCOT ANALYSIS 24
8.6.3. PRODUCT BENCHMARKING 25
8.6.4. STRATEGIC INITIATIVES 25
8.7. COHEREX MEDICAL INC. 25
8.7.2. SCOT ANALYSIS 25
8.7.3. PRODUCT BENCHMARKING 25
8.7.4. STRATEGIC INITIATIVES 25
8.8. CONTEC MEDICAL SYSTEMS CO. LTD. 25
8.8.2. SCOT ANALYSIS 25
8.8.3. PRODUCT BENCHMARKING 25
8.8.4. STRATEGIC INITIATIVES 25
8.9. COOK MEDICAL INC. 25
8.9.2. SCOT ANALYSIS 25
8.9.3. PRODUCT BENCHMARKING 25
8.9.4. STRATEGIC INITIATIVES 25
8.10. EBR SYSTEMS INC. 25
8.10.2. SCOT ANALYSIS 25
8.10.3. PRODUCT BENCHMARKING 25
8.10.4. STRATEGIC INITIATIVES 25
8.11. EDAN INSTRUMENTS INC. 25
8.11.2. SCOT ANALYSIS 25
8.11.3. PRODUCT BENCHMARKING 25
8.11.4. STRATEGIC INITIATIVES 25
8.12. HEARTSINE TECHNOLOGIES INC. 26
8.12.2. SCOT ANALYSIS 26
8.12.3. PRODUCT BENCHMARKING 26
8.12.4. STRATEGIC INITIATIVES 26
8.13. HEARTWARE INC. 26
8.13.2. SCOT ANALYSIS 26
8.13.3. PRODUCT BENCHMARKING 26
8.13.4. STRATEGIC INITIATIVES 26
8.14. IVY BIOMEDICAL SYSTEMS INC. 26
8.14.2. SCOT ANALYSIS 26
8.14.3. PRODUCT BENCHMARKING 26
8.14.4. STRATEGIC INITIATIVES 26
8.15. LIFEWATCH SERVICES INC. 26
8.15.2. SCOT ANALYSIS 26
8.15.3. PRODUCT BENCHMARKING 26
8.15.4. STRATEGIC INITIATIVES 26
TABLE 1 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY END USERS 2012-2022 ($ MILLION) 26
TABLE 2 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY HOSPITALS 2012-2022 ($ MILLION) 26
TABLE 3 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY HOME/ AMBULATORY 2012-2022 ($ MILLION) 26
TABLE 4 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY OTHERS 2012-2022 ($ MILLION) 27
TABLE 5 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY PRODUCT TYPE 2012-2022 ($ MILLION) 27
TABLE 6 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY ECG 2012-2022 ($ MILLION) 27
TABLE 7 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY RESTING ECG 2012-2022 ($ MILLION) 27
TABLE 8 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY STRESS ECG 2012-2022 ($ MILLION) 27
TABLE 9 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY HOLTER MONITORS 2012-2022 ($ MILLION) 27
TABLE 10 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY ECG BY LEAD TYPE 2012-2022 ($ MILLION) 27
TABLE 11 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY SINGLE LEAD 2012-2022 ($ MILLION) 27
TABLE 12 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY 3-6 LEAD 2012-2022 ($ MILLION) 27
TABLE 13 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY 12 LEAD 2012-2022 ($ MILLION) 27
TABLE 14 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY DEFIBRILLATORS 2012-2022 ($ MILLION) 27
TABLE 15 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 2012-2022 ($ MILLION) 27
TABLE 16 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY EXTERNAL DEFIBRILLATORS 2012-2022 ($ MILLION) 27
TABLE 17 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY PACEMAKERS 2012-2022 ($ MILLION) 27
TABLE 18 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY CARDIAC RESYNCHRONIZATION THERAPY DEVICES 2012-2022 ($ MILLION) 27
TABLE 19 GLOBAL ABLATION TECHNOLOGIES MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 27
TABLE 20 GLOBAL CARDIAC EQUIPMENT TECHNOLOGIES MARKET BY REGION 2012-2022 ($ MILLION) 27
TABLE 21 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 22 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 28
TABLE 23 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 24 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 25 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 26 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 27 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 28 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 29 MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 30 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 31 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 28
TABLE 32 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 33 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 34 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 35 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 36 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 37 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 38 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 39 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 40 SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 41 REST OF EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($MILLION) 29
TABLE 42 REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 29
TABLE 43 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 44 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 29
TABLE 45 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 46 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 47 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 48 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 49 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 50 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 51 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 29
TABLE 52 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 53 SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 29
TABLE 54 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 55 REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 56 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 57 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 30
TABLE 58 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 59 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 60 LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 61 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 62 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
FIGURE 1 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 2 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 4 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 5 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 6 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 7 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 8 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 9 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 10 REST OF EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($MILLION) 31
FIGURE 11 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 12 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 13 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 14 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 15 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 16 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 17 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 18 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 19 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)